Find out more about our Academic Medical Centre and efforts in Academic Medicine
Find out more about what JOAM do to support AM initiatives
Academic Medicine Executive Committee (AM EXCO)
Our appointed ACP leaders within the respective 15 ACPs
Guidelines, forms, and templates for Academic Medicine.
The SingHealth Duke-NUS Cell Therapy Centre (SDCT) was launched in May 2021 to provide a cluster-wide focal point in coordinating cell, tissue and gene therapy (CTGT) research and education, as well as clinical trials and services.
This integrated and virtual centre brings together the strengths and expertise of healthcare professionals across various specialties in SingHealth institutions, to leverage on advanced CTGT technologies to improve diagnostics, therapeutics, research and healthcare outcomes by providing seamless, holistic and quality patient-centric care.
SDCT aims to be a global leader in delivering CTGT products and technologies, with a vision to make cellular immunotherapy available to Singapore and the Asia-Pacific region.
Besides enhancing patient care, SDCT also focuses on formulating and coordinating cluster-wide efforts in the research and development of novel CTGT products and associated technologies.
Additionally, the Centre organises educational programmes such as the monthly Cell Therapy Lecture Series, bimonthly External Speaker Seminar Series and annual Cell Therapy Conference to equip medical professionals with knowledge of the use of cellular therapies in clinical trials and services.
SDCT will be organising more educational programmes in the near future.
Below are some programmes that may be relevant to general practitioners (GPs):
GPs who would like to know more about SDCT's educational programmes, or join the mailing list to be updated on SDCT's news, events and activities, please email to firstname.lastname@example.org.
The Centre works with the Advanced Cell Therapy Research Institute, Singapore (ACTRIS) and the Regenerative Medicine Institute of Singapore (REMEDIS), and closely coordinates efforts with other national and international stakeholders to establish Singapore as the regional hub of CTGT.
Cell Therapy Administration
Research & Development
Expertise in regulatory aspects and operations pertaining to cell therapies
GPs who would like to find out more, please contact the SingHealth Duke-NUS Cell Therapy Centre:
Email: email@example.comWebsite: www.singhealth.com.sg/cell-therapy-centre
HeadProf William HwangMedical Director, NCCS;Senior Consultant,Division of Medical Oncology, NCCS,Dept of Haematology, SGH
Deputy HeadProf Jodhbir Singh MehtaHead & Senior Consultant,Dept of Cornea & External Eye Disease, SNEC
Deputy Head & Principal Lead, EducationAsst Prof Francesca Lorraine LimConsultant,Dept of Haematology, SGH
Principal Lead, Regenerative MedicineProf Teh Bin TeanDeputy Medical Director (Research), NCCS
Principal Lead, Cellular ImmunotherapyAssoc Prof Toh Han ChongDeputy Medical Director (Strategic Partnerships);Senior Consultant,Division of Medical Oncology, NCCS
Principal Lead, Quality & RegulatoryClin Assoc Prof Aloysius HoSenior Consultant,Dept of Haematology, SGH
Campus Site Chief @CGHDr Vincent Tay Khwee SoonAssociate Consultant,Dept of Surgery, CGH
Campus Site Chief @KKHDr Soh Shui YenHead & Senior Consultant,Haematology/Oncology Service, KKH
Campus Site Chief @SKHAsst Prof Wong Keng Lin, FrancisConsultant,Dept of Orthopaedic Surgery, SKH